We are pleased to inform that National Accreditation Board for Hospitals and Health Care (NABH) is organizing one day training Programme on New Drugs & Clinical Trial Rules (NDCT) through virtual platform. The details are as follows.
The New drugs and Clinical trials rules 2019 (New rules) was introduced on 19th March 2019 by Government of India. New rules have set specific requirements for ethics committee (EC). The EC is required to follow requirements set as per New rules and to forward their report to Central Licensing Authority (CLA). It is now mandatory for all the research staffs to know the Schedules and chapters included in NDCT Rule for conducting Clinical Trial in India.
The objective of this programme:
The new rules aim to promote clinical research in India by providing for a predictable, transparent and effective regulation for clinical trials and by ensuring faster accessibility of new drugs to the Indian population
Who should attend?
Clinical research professionals, Investigators, Contract Research Organizations (CROs), nursing professional, Ethics committee members, Clinical research staff, etc. NABH encourages keeping the group of a mix of professionals from diverse healthcare background.
The registration can be done by filling the registration form at our website www.nabh.co. Registration fee (non-refundable & non-changeable) is Rs. 4,000/- + GST@ 18% (total Rs. 4720/-) per participant. Fees concession of 10% is being provided for the members of Quality Council of India (http://www.qcin.org/nbqp/PMS/).
Resource Material: A descriptive course notes on NDCT rules shall be provided to each participant electronically.
Limited Seats are available and will be allotted on ‘first cum first serve’ basis.
Programme Timings: 02:00 pm to 06:00 pm
For registration and any other related query please contact:
Assistant Director | NABH
National Accreditation Board for Hospitals & Healthcare Providers
Quality Council of India | www.qcin.org
ITPI Building, 5th Floor, 4-A,
I P Estate, Ring Road, New Delhi - 110002, India
Facebook | Linked In| Twitter